Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today announces the repayment of its $600,000 promissory note (the “Note”) to Nirland Limited (“Nirland”) and provided an ...
Conduit Pharmaceuticals partners with Charles River to evaluate the efficacy of its lead programme in a pre-clinical lupus model, utilizing ...
A STAT examination shows how AI-powered biotechs like Absci and Generate Biomedicines routinely aggrandize their AI ...
Isomorphic Labs, a spin-off from DeepMind, is applying AI-first principles to drug discovery rather than just protein ...
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
A Hong Kong biotech start-up is working with a number of university partners to conduct global clinical trials that could lead to a better way of delivering drugs for prevalent eye diseases.
AI creates anti-cancer molecules for proteins that previously could not be targeted pharmacologically by leveraging quantum ...
The situation was reversed only 25 years ago. So, the Biotech Centre of Excellence will project the group towards the future of medicine and science. It is a strong message for Italy, and Parma in ...
Prolific Machines, a biotechnology innovator unlocking unprecedented cellular control with light, appoints Christina Perry as CFO.
In a recent webinar conducted by IQVIA and pharmaphorum, several experts gathered to give their views on the current state of UK biotech and what the future might look like. Steve Bates ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback